An Unlikely Pandemic Pairing: Facemasks Embedded with Ostrich Antibodies That Detect COVID-19 under UV Light

Japanese scientists who developed the detection method hope to use it to create ‘easy testing kits that anyone can use’ What do ostriches and humans have in common during the current COVID-19 pandemic? The unexpected answer is that ostrich antibodies can be used to identify humans infected with COVID-19. If proven viable in healthcare settings, the possibility exists that new clinical laboratory tests could be developed based on wearable diagnostics technologies that pathologists would...

Theranos Whistleblower Tyler Shultz Celebrates Former CEO Elizabeth Holmes’ Guilty Verdict by Popping Champagne with Family Members

As a Theranos insider and whistleblower, Tyler Schultz was able to provide information about the ongoing failures in medical laboratory testing at the once-high-flying Theranos to regulators and at least one journalist What’s it like to be a whistleblower in a high-profile clinical laboratory? Few clinical laboratory workers will ever know. But former Theranos employee Tyler Shultz does know, after helping to expose the Silicon Valley blood-testing startup’s deceptions. The 31-year-old Shultz...

University of Colorado Researchers Develop Miniature Colonoscopy Robot Capable of Collecting Biopsies and Transmit Diagnostic Information in Real Time

GI pathologists will be interested in how the Endoculus device uses tank-like treads to traverse the gastrointestinal tract, where it can capture images and perform biopsies Gastroenterologists (GI) may soon gain a useful new tool for use in gathering both biopsies and diagnostic information when examining the gastrointestinal tract. Ongoing development of a new robotic device promises both capabilities using technology that will be of interest to GI pathologists and clinical laboratory...

Theranos Ex-CEO Elizabeth Holmes Convicted on Three Counts of Wire Fraud and One Count of Conspiracy to Commit Fraud after Seven Days of Jury Deliberations

Split verdict could still mean considerable prison time for the one-time high-flying Silicon Valley entrepreneur In a trial generating unprecedented interest among clinical laboratory scientists, former Theranos CEO Elizabeth Holmes was found guilty in federal court this week on four charges of defrauding investors. Holmes faces up to 20 years in prison as well as a fine of $250,000 plus restitution for each count, though sentencing experts predict a much lighter sentence for the 37-year-old...

Genomics England Increases Goal of Whole Genome Sequencing Project from 100,000 to Five Million Sequences in Five Years

Genomic sequencing continues to benefit patients through precision medicine clinical laboratory treatments and pharmacogenomic therapies What better proof of progress in whole human genome screening than the recent announcement that the United Kingdom’s 100,000 Genome Project has not only achieved that milestone, but will now increase the goal to five million whole human genomes? This should be welcome news to clinical laboratory managers, as it means their labs will be positioned as the...

Two Important Aspects for Clinical Laboratories to Consider Following Elizabeth Holmes’ Conviction

The Theranos trial brought plenty of media attention, but beneath the hype, laboratory managers have lessons to ponder Editor’s note: This is a special edition of Dark Daily brought to you by The Dark Report. The conviction of disgraced Theranos founder and former CEO Elizabeth Holmes brings a close to one of the most infamous healthcare and high-tech trials ever. But the high-profile case should not camouflage critical, everyday lessons for clinical laboratories. Holmes was found guilty on...
;